Hooven Michael D

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$199,101.37
Insider Sells Quantity
8
Insider Sells Sum
$5.61M

Insider Activity of Hooven Michael D

The largest purchase of all time was on 2008-06-09 and amounted to 9600 shares of AtriCure, Inc. for $99,830.

The largest sale of all time was on 2015-03-30 and amounted to 85000 shares of AtriCure, Inc. for $1.79M.

Biography of Hooven Michael D

No biography is available at this moment.

2017-05-05SaleAtriCure, Inc.
ATRC
director
20,000
0.0425%
$15.79$315,800-8.52%
2015-04-01SaleAtriCure, Inc.
ATRC
director
37,268
0.1352%
$20.50$763,994+4.76%
2015-03-31SaleAtriCure, Inc.
ATRC
director
20,000
0.0733%
$20.51$410,200+5.78%
2015-03-30SaleAtriCure, Inc.
ATRC
director
85,000
0.3142%
$21.01$1.79M+3.21%
2014-12-31SaleAtriCure, Inc.
ATRC
director
57,732
0.2137%
$20.00$1.15M+8.72%
2012-09-14PurchaseAtriCure, Inc.
ATRC
director
2,090
0.013%
$7.69$16,069+7.24%
2012-09-13PurchaseAtriCure, Inc.
ATRC
director
2,220
0.0131%
$7.37$16,353+6.06%
2012-09-12PurchaseAtriCure, Inc.
ATRC
director
2,300
0.0142%
$7.09$16,319+14.57%
2012-09-11PurchaseAtriCure, Inc.
ATRC
director
2,290
0.0142%
$7.18$16,446+13.32%
2012-09-10PurchaseAtriCure, Inc.
ATRC
director
2,430
0.015%
$7.15$17,367+13.96%
2012-09-07PurchaseAtriCure, Inc.
ATRC
director
2,430
0.0151%
$6.88$16,718+18.68%
2012-03-13SaleAtriCure, Inc.
ATRC
director
7,000
0.0442%
$10.02$70,140-19.07%
2011-06-13SaleAtriCure, Inc.
ATRC
director
60,000
0.3713%
$14.00$840,000-29.47%
2010-11-10SaleAtriCure, Inc.
ATRC
director
33,272
0.2155%
$8.10$269,437+35.04%
2008-06-09PurchaseAtriCure, Inc.
ATRC
director
9,600
0.0685%
$10.40$99,830-74.78%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.